It would be interesting to explore whether resistance to oxidative stress driven by this pool of ribosomes is also present in other cancers as well as evaluate whether acquisition of mutations in Rpl10 could be a possible resistance approach adopted by cancer cells during tumor development. The gene discussed is RPL10; the disease is cancer.